Koroner Reoperasyonlar

Cosgrove DM, Loop FD, Lytle BW, Gill CC, Golding LA, Gibson C, et al. Predictors of reoperation after myocardial revascularization. J Thorac Cardiovasc Surg. 1986; 92: 811-821.

Lytle BW, Loop FD, Cosgrove DM, Taylor PC, Goormastic M, Peper W, et al. Fifteen hundred coronary reoperations. Results and determinants of early and late survival. J Thorac Cardiovasc Surg. 1987; 93: 847-859.

Lytle BW, Loop FD, Taylor PC, Simpfendorfer C, Kramer JR, Ratliff NB, et al. Vein graft disease: the clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg. 1992; 103: 831-840.

Turk T. Early graft failure after coronary artery bypass grafting: diagnosis and treatment. The European Research Journal. 2016; 2: 85-92. https://doi.org/10.18621/eurj.2016.5000183008

Carey JS, Cukingnan RA, Singer LK. Quality of life after myocardial revascularization. Effect of increasing age. J Thorac Cardiovasc Surg. 1992; 103: 108-115.

Christenson JT, Schmuziger M. Third-time coronary bypass operation. Analysis of selection mechanisms, results and long-term follow-up. Eur J Cardiothorac Surg. 1994; 8: 500-504. https://doi.org/10.1016/1010-7940(94)90022-1

Ghanta RK, Kaneko T, Gammie JS, Sheng S, Aranki SF. Evolving trends of reoperative coronary artery bypass grafting: An analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. The Journal of Thoracic and Cardiovascular Surgery. 2013; 145: 364-372. https://doi.org/10.1016/j.jtcvs.2012.10.051

Iscan HZ, Kandemir O, Gol MK, Saritas A, Tasdemir O. Coronary reoperations without the use of cardiopulmonary bypass. Cardiovasc Surg. 2003; 11: 155-158. https://doi.org/10.1016/s0967-2109(02)00105-9

Neitzel GF, Barboriak JJ, Pintar K, Qureshi I. Atherosclerosis in aortocoronary bypass grafts. Morphologic study and risk factor analysis 6 to 12 years after surgery. Arteriosclerosis. 1986; 6: 594-600. https://doi.org/10.1161/01.atv.6.6.594

Ratliff NB, Myles JL. Rapidly progressive atherosclerosis in aortocoronary saphenous vein grafts. Possible immune-mediated disease. Arch Pathol Lab Med. 1989; 113: 772-776.

Solymoss BC, Leung TK, Pelletier LC, Campeau L. Pathologic changes in coronary artery saphenous vein grafts and related etiologic factors. Cardiovasc Clin. 1991; 21: 45-65.

Bourassa MG, Campeau L, Lespérance J. Changes in grafts and in coronary arteries after coronary bypass surgery. Cardiovasc Clin. 1991; 21: 83-100.

Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg. 1985; 89: 248-258.

Kalan JM, Roberts WC. Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments of veins. Am Heart J. 1990; 119: 1164-1184. https://doi.org/10.1016/s0002-8703(05)80249-2

Zhao DX, Leacche M, Balaguer JM, Boudoulas KD, Damp JA, Greelish JP, et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol. 2009; 53: 232-241. https://doi.org/10.1016/j.jacc.2008.10.011

FitzGibbon GM, Leach AJ, Kafka HP, Keon WJ. Coronary bypass graft fate: long-term angiographic study. J Am Coll Cardiol. 1991; 17: 1075-1080. https://doi.org/10.1016/0735-1097(91)90834-v

Gavaghan TP, Gebski V, Baron DW. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation. 1991; 83: 1526-1533. https://doi.org/10.1161/01.cir.83.5.1526

Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145: e18-e114. https://doi.org/10.1161/CIR.0000000000001038

Domanski M, Tian X, Fleg J, Coady S, Gosen C, Kirby R, et al. Pleiotropic Effect of Lovastatin, With and Without Cholestyramine, in the Post Coronary Artery Bypass Graft (Post CABG) Trial. The American Journal of Cardiology. 2008; 102: 1023-1027. https://doi.org/https://doi.org/10.1016/j.amjcard.2008.05.053

Carpentier A, Guermonprez JL, Deloche A, Frechette C, DuBost C. The aorta-to-coronary radial artery bypass graft. A technique avoiding pathological changes in grafts. Ann Thorac Surg. 1973; 16: 111-121. https://doi.org/10.1016/s0003-4975(10)65825-0

Fisk RL, Brooks CH, Callaghan JC, Dvorkin J. Experience with the radial artery graft for coronary artery bypass. Ann Thorac Surg. 1976; 21: 513-518. https://doi.org/10.1016/s0003-4975(10)63919-7

Chiu CJ. Why do radial artery grafts for aortocoronary bypass fail? A reappraisal. Ann Thorac Surg. 1976; 22: 520-523. https://doi.org/10.1016/s0003-4975(10)64468-2

Deb S, Cohen EA, Singh SK, Une D, Laupacis A, Fremes SE. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol. 2012; 60: 28-35. https://doi.org/10.1016/j.jacc.2012.03.037

Gaudino M, Tondi P, Benedetto U, Milazzo V, Flore R, Glieca F, et al. Radial Artery as a Coronary Artery Bypass Conduit: 20-Year Results. J Am Coll Cardiol. 2016; 68: 603-610. https://doi.org/10.1016/j.jacc.2016.05.062

Gaudino M, Hameed I, Robinson NB, Ruan Y, Rahouma M, Naik A, et al. Angiographic Patency of Coronary Artery Bypass Conduits: A Network Meta-Analysis of Randomized Trials. J Am Heart Assoc. 2021; 10: e019206. https://doi.org/10.1161/jaha.120.019206

Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145: e4-e17. https://doi.org/10.1161/cir.0000000000001039

Gaudino M, Benedetto U, Fremes S, Ballman K, Biondi-Zoccai G, Sedrakyan A, et al. Association of Radial Artery Graft vs Saphenous Vein Graft With Long-term Cardiovascular Outcomes Among Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis. Jama. 2020; 324: 179-187. https://doi.org/10.1001/jama.2020.8228

Buxton BF, Hayward PA, Raman J, Moten SC, Rosalion A, Gordon I, et al. Long-Term Results of the RAPCO Trials. Circulation. 2020; 142: 1330-1338. https://doi.org/10.1161/circulationaha.119.045427

Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986; 314: 1-6. https://doi.org/10.1056/nejm198601023140101

Lytle BW, Loop FD. Superiority of bilateral internal thoracic artery grafting: it's been a long time comin'. Circulation. 2001; 104: 2152-2154.

Lytle BW, Loop FD, Taylor PC, Goormastic M, Stewart RW, Novoa R, et al. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg. 1993; 105: 605-612; discussion 612-604.

Merrill WH, Elkins CC, Stewart JR, Frist WH, Bender HW. Third-time coronary artery bypass grafting: Midterm results. The Annals of Thoracic Surgery. 1993; 55: 582-584. https://doi.org/https://doi.org/10.1016/0003-4975(93)90253-E

Sanchez JA, Smith CR, Drusin RE, Reison DS, Malm JR, Rose EA. High-risk reparative surgery. A neglected alternative to heart transplantation. Circulation. 1990; 82: Iv302-305.

Blakeman BM, Pifarré R, Sullivan H, Costanzo-Nordin MR, Zucker MJ. High-risk heart surgery in the heart transplant candidate. J Heart Transplant. 1990; 9: 468-472.

David Jr C. Reoperations in cardiac surgery. Springer Science & Business Media: 2012.

Grondin CM, Pomar JL, Hébert Y, Bosch X, Santos JM, Enjalbert M, et al. Reoperation in patients with patent atherosclerotic coronary vein grafts. A different approach to a different disease. J Thorac Cardiovasc Surg. 1984; 87: 379-385.

Elami A, Laks H, Merin G. Technique for reoperative median sternotomy in the presence of a patent left internal mammary artery graft. J Card Surg. 1994; 9: 123-127. https://doi.org/10.1111/j.1540-8191.1994.tb00837.x

Coltharp WH, Decker MD, Lea JWt, Petracek MR, Glassford DM, Jr., Thomas CS, Jr., et al. Internal mammary artery graft at reoperation: risks, benefits, and methods of preservation. Ann Thorac Surg. 1991; 52: 225-228; discussion 229. https://doi.org/10.1016/0003-4975(91)91340-2

Gundry SR, Razzouk AJ, Vigesaa RE, Wang N, Bailey LL. Optimal delivery of cardioplegic solution for "redo" operations. J Thorac Cardiovasc Surg. 1992; 103: 896-901.

Grondin CM. The removal of still functioning albeit old grafts: not in our genes? Ann Thorac Surg. 1986; 42: 122-123. https://doi.org/10.1016/s0003-4975(10)60502-4

Strauss ER, Taneja M, Booth R, Sankova S, Anders MG. Antifibrinolytics in Cardiac Surgery: What Is the Best Practice in 2022? Current Anesthesiology Reports. 2022; 12: 501-507. https://doi.org/10.1007/s40140-022-00538-w

Armellin G, Vinciguerra A, Bonato R, Pittarello D, Giron GP. Tranexamic acid in primary CABG surgery: high vs low dose. Minerva Anestesiol. 2004; 70: 97-107.

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, et al. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. New England Journal of Medicine. 2017; 376: 136-148. https://doi.org/doi:10.1056/NEJMoa1606424

Takagi H, Manabe H, Kawai N, Goto SN, Umemoto T. Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials. Interact Cardiovasc Thorac Surg. 2009; 9: 98-101. https://doi.org/10.1510/icvts.2008.198325

Arom KV, Emery RW. Decreased postoperative drainage with addition of epsilon-aminocaproic acid before cardiopulmonary bypass. Ann Thorac Surg. 1994; 57: 1108-1112; discussion 1112-1103. https://doi.org/10.1016/0003-4975(94)91338-2

Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg. 1989; 97: 364-372.

Cosgrove DM, 3rd, Heric B, Lytle BW, Taylor PC, Novoa R, Golding LA, et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg. 1992; 54: 1031-1036; discussion 1036-1038. https://doi.org/10.1016/0003-4975(92)90066-d

Vincent GM, Janowski M, Menlove R. Protamine allergy reactions during cardiac catheterization and cardiac surgery: risk in patients taking protamine-insulin preparations. Cathet Cardiovasc Diagn. 1991; 23: 164-168. https://doi.org/10.1002/ccd.1810230303